This review aims to critically analyze: (1) the anatomy of the prostate gland's lymphatic drainage, (2) the anatomic boundaries of PLND and which dissection may be superior, (3) who should undergo a ...

Results from the PHENIX-I trial support skipping pelvic lymphadenectomy in women with early cervical cancer who have a negative sentinel lymph node biopsy. Omitting pelvic lymphadenectomy in these ...

Expert Rev Anticancer Ther. 2013;13(11):1281-1295. The extended template comprises the standard package with the addition of presacral area, the proximal common iliac and aortic bifurcation. The ...

Sentinel lymph node (SLN) biopsy for early cervical cancer achieved non-inferiority versus pelvic lymphadenectomy, according to results of a large randomized study from China. Patients assigned to SLN ...

Right Pelvic Lymphocele Investigators have explored various strategies to prevent lymphoceles from forming. Most prostatectomies are now being done with concomitant lymphadenectomy. A few factors are ...

End Point Definitions and Surrogacy in Prostate Cancer: Will Metastasis-Free Survival Become Event-Free Survival With Advances in Molecular Imaging? Two previous trials have evaluated the role of ...

Treatment of pelvic nodes individualized by inclusion of sentinel nodes (SN) can be easily integrated into an IMRT-based treatment strategy, according to the new study conducted by a group of ...

Please provide your email address to receive an email when new articles are posted on . The addition of pelvic lymph node treatment and short-term androgen deprivation therapy to prostate bed salvage ...

"Given the high probability of treatment failure, surgical salvage should be offered, ideally, for a select group of patients with recurrent or persistent cervical cancer who have a high probability ...

Drugs can be safely delivered to cancerous lymph nodes via the lymphatic system and then released inside the nodes using sound waves. Tohoku University researchers tested the treatment on mice with ...

Show More David D. Yang, MD, Paul L. Nguyen, MD, and Anthony V. D'Amico, MD, PhD, Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute and Harvard Medical School ...